Clinical applications of EPR: Overview and perspectives

NMR in Biomedicine

Volumn 17, Issue 5, 2004, Pages 335-351

  Swartz, Harold M ^a   Khan, Nadeem ^a   Buckey, Jay ^a   Comi, Richard ^a   Gould, Lisa ^b   Grinberg, Oleg ^a   Hartford, Alan ^a   Hopf, Harriet ^c   Hou, Huagang ^a   Hug, Eugen ^a   Iwasaki, Akinori ^a   Lesniewski, Piotr ^a   Salikhov, Ildar ^a   Walczak, Tadeusz ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Clinical applications; Dosimetry; EPR spectroscopy; Human subjects; In vivo EPR; Ischemia; Oximetry

Indexed keywords

BIOMEDICAL ENGINEERING; FREE RADICALS; NITROGEN OXIDES; ONCOLOGY; OXIMETERS; OXYGEN; TISSUE;

MOLECULAR MOTION; OXIDATIVE STRESSES; PERIPHERAL VASCULAR DISEASES; PHARMACOLOGY;

PARAMAGNETIC RESONANCE;

ALPHA TOCOPHEROL; ANTIOXIDANT; FREE RADICAL; NITRIC OXIDE;

ACCIDENT; ACCURACY; ATOMIC WARFARE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; DRUG DELIVERY SYSTEM; ELECTRON SPIN RESONANCE; HUMAN; IN VIVO STUDY; IONIZING RADIATION; MEDICAL INSTRUMENTATION; OXIDATIVE STRESS; OXIMETRY; OXYGEN TENSION; OXYGEN TISSUE LEVEL; PATIENT POSITIONING; PERIPHERAL VASCULAR DISEASE; PH MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RADIATION MEASUREMENT; REVIEW; SENSITIVITY ANALYSIS; TERRORISM; WOUND HEALING;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL MEDICINE; CONNECTIVE TISSUE; ELECTRON SPIN RESONANCE SPECTROSCOPY; EQUIPMENT DESIGN; HUMANS; ISCHEMIA; NEOPLASMS; OXYGEN; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

ANIMALIA;

EID: 4544246920     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.911     Document Type: Review

References (117)

1. Swartz HM, Berliner L. Introduction to in vivo EPR. In Biological Magnetic Resonance - Volume 18: In Vivo EPR (ESR): Theory and Applications, Berliner LJ (ed.). Plenum Press: New York, 2003; 1-21.
2. Swartz HM. The measurement of oxygen in vivo using EPR techniques. In Biological Magnetic Resonance - Volume 18: In Vivo EPR (ESR): Theory and Applications, Berliner LJ (ed.). Plenum Press: New York, 2003; 403-440.
3. Khan N, Swartz H. Measurements of in vivo parameters pertinent to ROS/RNS using EPR spectroscopy. Mol. Cell. Biochem. 2002; 234/235: 341-357.
4. Swartz HM, Khan N. EPR spectroscopy of function in vivo: origins, achievements, and future possibilities. In Biomedical ESR: A Volume in the Biological Magnetic Resonance Series, Eaton SS, Eaton GR, Berliner LJ (eds). Kluwer Academic: Dordrecht, 2004; 197-228.
5. -. Free Rad. Biol. Med. 1999; 27: 329-333.
6. Villamena FA, Zweier JL. Detection of reactive oxygen and nitrogen species by EPR spin trapping. Antioxid. Redox Signal. 2004; 6: 619-629.
7. Knecht KT, Mason RP. In vivo spin trapping of xenobiotic free radical metabolites. Arch. Biochem. Biophys. 1993; 303: 185-194.
8. Fuji H, Zhao B, Koscielniak J, Berliner J. In vivo EPR studies of the metabolic fate of nitrosobenzene in the mouse. Magn. Reson. Med. 1994; 31: 77-80.
9. Fujii S, Yoshimura. T. Detection and imaging of endogenously produced nitric oxide with electron paramagnetic resonance spectroscopy. Antioxid. Redox Signal. 2000; 2: 879-901.
10. Madhani M, James P, Barchowsky A, Klei L, Ross C, Jackson SK, Swartz HM. Anti-bacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim. Biophys. Acta 2002; 1588: 232-240.
11. 2 and NO by electron paramagnetic resonance. Meth. Enzymol. 2002; 359: 52-66.
12. Miyake M, Liu KJ, Walczak T, Swartz HM. In vivo EPR dosimetry of accidental exposures to radiation: experimental results indicating the feasibility of practical use in human subjects. Appl. Radiat. Isotopes 2000; 52: 1031-1038.
13. Iwasaki A, Grinberg O, Walczak T, Swartz HM. In vivo measurements of EPR signals in whole human teeth. Appl. Radiat. Isot. 2004 (in press).
14. Swartz HM. The measurement of oxygen in vivo using EPR techniques. In Biological Magnetic Resonance - Volume 20: In vivo EPR (ESR): Theory and Applications, Berliner LJ (ed.). Plenum Press: New York, 2002; 403-440.
15. Dunn JF, Swartz HM. In vivo electron paramagnetic resonance oximetry with particulate materials. Methods 30: 159-166.
16. He G, Samouilov A, Kuppusamy P, Zweier JL. In vivo imaging of free radicals: applications from mouse to man. Mol. Cell. Biochem. 2002; 234-235: 359-367.
17. Yokoyama H, Lin Y, Itoh O, Ueda Y, Nakajima A, Ogata T, Sato T, Ohya-Nishiguchi H, Kamada H. EPR imaging for in vivo analysis of the half-life of a nitroxide radical in the hippocampus and cerebral cortex of rats after epileptic seizures. Free Rad. Biol. Med. 1999; 3-4: 442-448.
18. Yokoyama H, Itoh O, Aoyama M, Obara H, Ohya H, Kamada H. In vivo temporal EPR imaging of the brain of rats by using two types of blood-brain barrier-permeable nitroxide radicals. Magn. Reson. Imag. 2002; 20: 277-284.
19. Cafiso DS. Electron paramagnetic resonance methods for measuring pH gradients, transmembrane potentials, and membrane dynamics. Meth. Enzymol. 1989; 172: 331-345.
20. Halpern HJ, Chandramouli GV, Barth ED, Yu C, Peric M, Grdina DJ, Teicher BA. Diminished aqueous microviscosity of tumors in murine models measured with in vivo radio frequency electron paramagnetic resonance. Cancer Res. 1999; 59: 5836-5841.
21. Gallez B, Bacic G, Swartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn. Reson. Med. 1996; 35: 14-19.
22. Eckburg JJ, Chato JC, Liu KJ, Grinstaff MW, Swartz HM, Suslick KS, Auteri FP. The measurement of temperature with electron paramagnetic resonance spectroscopy. J. Biomech. Eng. 1996; 118: 193-200.
23. Borbat PP, Costa-Filho AJ, Earle KA, Moscicki JK, Freed JH. Electron spin resonance in studies of membranes and proteins. Science 2001; 291: 266-269.
24. Yamada KI, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell JB, Krishna MC. Feasibility and assessment of noninvasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol. 2002; 43: 433-440.
25. Ilangovan G, Li H, Zweier JL, Kuppusamy P. In vivo measurement of tumor redox environment using EPR spectroscopy. Mol. Cell Biochem. 2002; 234-235: 393-398.
26. Khramtsov VV, Yelinova VI, Glazachev YI, Reznikov VA, Zimmer G. Quantitative determination and reversible modification of thiols using imidazolidine biradical disulfide label. J. Biochem. Biophys. Meth. 1997; 35: 115-128.
27. Dobrucki JW, Sutherland RM, Swartz HM. Non-perturbing test for cytotoxicity in isolated cells and spheroids, using electron paramagnetic resonance. Magn. Reson. Med. 1991; 19: 42-55.
28. Gallez B, Bacic G, Dunn J, Goda F, Jiang J, O'Hara JA, Swartz HM. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues in vivo EPR and MRI studies. Magn. Reson. Med. 1996; 35: 97-106.
29. Liu KJ, Shi X. In vivo reduction of chromium (VI) and its related free radical generation. Mol. Cell Biochem. 2001; 222: 41-47.
30. James PE, Jackson SK, Grinberg O, Swartz HM. The effects of endotoxin on oxygen consumption of various cell types in vitro: an EPR oximetry study. Free Rad. Biol. Med. 1995; 18: 641-647.
31. Glasgow BJ, Gasymov OK, Abduragimov AR, Yusifov TN, Altenbach C, Hubbell WL. Side chain mobility and ligand interactions of the G strand of tear lipocalins by site-directed spin labeling. Biochemistry 1999; 38: 13707-13716.
32. Mader K, Gallez B, Swartz HM. In vivo EPR: an effective new tool for studying pathophysiology, physiology, and pharmacology. Appl. Radiat. Isot. 1996; 47: 1663-1667.
33. Mader K. Pharmaceutical applications of in vivo EPR. Phys. Med. Biol. 1998; 43: 1931-1935.
34. Mader K, Bacic G, Domb A, Elmalak O, Langer R, Swartz HM. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J. Pharm. Sci. 1997; 86: 126-134.
35. He G, Kumar KV, Kuppusamy P, Zweier JL. In vivo measurement and mapping of skin redox stress induced by ultraviolet light exposure. Free Rad. Biol. Med. 2004; 36: 665-672.
36. Fuchs J, Groth N, Herrling T. Applications of in vivo EPR spectroscopy and imaging to skin. In Biological Magnetic Resonance - Volume 18: In vivo EPR (ESR): Theory and Applications, Berliner LJ (ed.). Plenum Press: New York, 2003; 483-513.
37. Swartz HM, Dunn JF. Measurements of oxygen in tissues: overview and perspectives on methods. In Oxygen Transport to Tissue XXIV Dunn JF, Swartz HM (eds). Advances in Experimental Medicine and Biology, Vol. 530. Plenum Press: New York, 2003; 1-12.
38. Krishna MC, English S, Yamada K, Yoo J, Murugesan R, Devasahayam N, Cook JA, Golman K, Ardenkjaer-Larsen JH, Subramanian S, Mitchell JB. Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proc. Natl Acad. Sci. USA 2002; 99: 2216-2221.
39. Williams BB, al Hallaq H, Chandramouli GV, Barth ED, Rivers JN, Lewis M, Galtsev VE, Karczmar GS, Halpern HJ. Imaging spin probe distribution in the tumor of a living mouse with 350 MHz EPR: correlation with BOLD MRI. Magn. Reson. Med. 2002; 47: 634-638.
40. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol. 2001; 177: 462-468.
41. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 285-289.
42. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 1996; 41: 31-39.
43. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993; 26: 45-50.
44. Rofstad EK, Sundfor K, Lyng H, Trope CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br. J. Cancer 2000; 83: 354-359.
45. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother. Oncol. 1999; 53: 99-104.
46. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ, Hill RP. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 1998; 48: 149-156.
47. Nordsmark M, Alsner J, Keller J, Nielsen OS, Jensen OM, Horsman MR, Overgaard J. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br. J. Cancer 2001; 84: 1070-1075.
48. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996; 56: 941-943.
49. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Dodge RK, Charles HC, Samulski TV, Prosnitz LR, Dewhirst MW. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 1996; 56: 5347-5350.
50. Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. Int. J. Radiat. Oncol. Biol. Phys. 2003; 57: 391-401.
51. 2 study. Cancer 2000; 89: 2018-2024.
52. 2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. Urology 2002; 60: 634-639.
53. 2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int. J. Hypertherm. 2003; 19: 498-506.
54. Vaupel P, Hockel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. Int. J. Oncol. 2000; 17: 869-879.
55. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Cemazar M, Auersperg M, Swartz HM. Reduced tumor oxygenation by treatment with Vinblastine. Cancer Res. 2001; 6: 4266-4271.
56. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz H, Cemazar M. Reduced blood flow and oxygenation in SA-1 tumors after electrochemotherapy with cisplatin. Br. J. Cancer 2002; 87: 1047-1054.
57. Jordan BF, Gregoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara J, Vanhulle V, Delzenne N, Gallez B. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide dependent decrease of the tumor cells oxygen consumption. Cancer Res. 2002; 62: 3555-3561.
58. Jordan BF, Beghein N, Aubry M, Gregoire V, Gallez B. Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSa II murine tumors. Int. J. Cancer 2003; 103: 138-141.
59. Jordan BF, Sonveaux P, Feron O, Gregoire V, Beghein N, Gallez B. Nitric oxide mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55: 1066-1073.
60. Goda F, O'Hara JA, Rhodes ES, Liu KJ, Dunn JF, Bacic G, Swartz HM. Changes of oxygen tension in experimental tumors after a single dose of x-ray irradiation. Cancer Res. 1995; 55: 2249-2252.
61. 2 in a murine tumor following radiation: an in vivo electron paramagnetic resonance oximetry study. Radiat. Res. 1995; 144: 222-229.
62. O'Hara JA, Goda F, Dunn JF, Swartz HM. Potential for EPR oximetry to guide treatment planning for tumors. Adv. Exp. Med. Biol. 1997; 428: 233-242.
63. 2 measurements by electron paramagnetic resonance oximetry. Radiat. Res. 1998; 150: 549-556.
64. Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Makki M, Demidenko E, Lu S, Steffen RP, Swartz HM. Effect of the allosteric hemoglobin modifier RSR-13 on oxygenation in murine tumors: an in vivo EPR oximetry and BOLD MRI study. Int. J. Radiat. Oncol. Biol. Phys. 2004; 59(3): 834-843.
65. Pogue BW, O'Hara JA, Liu KJ, Hasan T, Swartz H. Photodynamic treatment of the RIF-1 tumor with verteportin with online monitoring of tissue oxygen using electron paramagnetic resonance oximetry. SPIE: Laser Tissue Interact. X 1999; 3601: 108-114.
66. Pogue BW, Paulsen KD, O'Hara JA, Wilmot CM, Swartz HM. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and Eppendorf measurements. Radiat. Res. 2001; 155(1 Pt 1): 15-25.
67. 2 changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp. Biochem. Physiol. Pt A 2002; 132: 177-184.
68. Smirnov AI, Norby SW, Walczak T, Liu KJ, Swartz HM. Physical and instrumental considerations in the use of lithium phthalocyanine for measurements of the concentration of oxygen. J. Magn. Reson. 1994; 103: 95-102.
69. Grinberg OY, Smirnov AI, Swartz HM. High spatial resolution multi-site EPR oximetry: the use of a convolution-based fitting methods. J. Magn. Reson. 2001; 152: 247-258.
70. Grinberg VO, Smirnov AL, Grinberg OY, Grinberg SA, O'Hara JA, Swartz HM. Practical experimental conditions and limitations for high spatial resolution multi-site EPR oximetry. Appl. Magn. Reson. 2004 (in press).
71. Khan N, Hou H, Hein P, Comi RJ, Buckey JC, Grinberg O, Salikhov I, Lu SY, Wallach H, Swartz HM. Black magic and EPR oximetry: from lab to initial clinical trials. Oxygen Transport to Tissue, Okunieff P (ed.). Plenum Press: New York, 2004 (in press).
72. 2 in a well established model wound healing. International Confrence on Wound Healing, Oxygen, and Emerging Therapeutics, Columbus, OH, 2002.
73. Gould LJ, Mushkudiani J, Hou H, Grinberg OY, Grinberg S, Swartz HM. Use of EPR spectroscopy to measure tissue oxygen in an ischemic flap model. Wound Repair Regen. 2004; 12: A29.
74. Smirnov AI, Norby SW, Clarkson RB, Walczak T, Swartz HM. Simultaneous multi-site EPR spectroscopy in vivo. Magn. Reson. Med. 1993; 30: 213-220.
75. Rizk M, Witte MB, Barbul A. Nitric oxide and wound healing. World J Surg. 2004; 28: 301-306.
76. Schwentker A, Billiar TR. Nitric oxide and wound repair. Surg. Clin. N. Am. 2003; 83: 521-530.
77. Swartz HM. Long-lived electron spin resonances in rats irradiated at room temperature. Radiat. Res. 1965; 24: 579-586.
78. Brady JM, Aarestad NO, Swartz HM. In vivo dosimetry by electron spin resonance spectroscopy. Health Phys. 1968; 15: 43-47.
79. Chumak V, Likhtarev I, Sholom S, Meckbach R, Krjuchkov VC. Chernobyl experience in field of retrospective dosimetry: reconstruction of doses to the population and liquidators involved in the accident. Radiat. Prot. Dosim. 1998; 77: 91-95.
80. Ivannikov A, Zhumadilov Zh, Gusev B, Miyazawa C, Liao L, Skvortsov VG, Stepanenko VF, Takada J, Hoshi M. Individual dose reconstruction among residents living in the vicinity of the Semipalatinsk Nuclear Test Site using EPR spectroscopy of tooth enamel. Health Phys. 2002; 83: 183-196.
81. Schauer DA, Coursey BM, Dick CE, McLaughlin WL, Puhl JM, Desrosiers MF, Jacobson AD. A radiation accident at an industrial accelerator facility. Health Phys. 1993; 65: 131-140.
82. Miyake M, Liu KJ, Walczak T, Swartz HM. In vivo EPR dosimetry of accidental exposures to radiation: experimental results indicating the feasibility of practical use in human subjects. Appl. Radiat. Isot. 2000; 52: 1031-1038.
83. Guidance for Industry and FDA Staff. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices, July 14, 2003. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Radiological Devices Branch, Division of Reproductive, Abdominal, and Radiological Devices, Office of Device Evaluation; www.fda.gov/cdrh/ode/guidance/793.pdf
84. Salikhov I, Swartz HM. Measurement of specific absorption rate for clinical EPR at 1200MHz. Magn. Reson. Med. 2004 (in press).
85. Nizam R, Siddiqi N, Landas SK, Kaplan DS, Holtzapple PG. Colonic tattooing with India ink: benefits, risks, and alternatives. Am. J. Gastroenterol. 1996; 91: 1804-1808.
86. Ellis KK, Fennerty MB. Marking and identifying colon lesions. Tattoos, clips, and radiology in imaging the colon. Gastrointest. Endosc. Clin. N. Am. 1997; 7: 401-411.
87. Price N, Gottfried MR, Clary E, Lawson DC, Baillie J, Mergener K, Westcott C, Eubanks S, Pappas TN. Safety and efficacy of India ink and indocyanine green as colonic tattooing agents. Gastrointest. Endosc. 2000; 51: 438-442.
88. Shata BA, Weinstock LB, Swanson PE, Thyssen EP. Long-term safety of India ink tattoos in the colon. Gastrointest. Endosc. 1997; 45: 153-156.
89. Berliner J, Fujii H. In vivo spin trapping of nitric oxide. Antioxid. Redox Signal. 2004; 6: 649-656.
90. Gallez B, Bacic G, Goda F, Jiang J, O'Hara JA, Dunn JF, Swartz HM. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies. Magn. Reson. Med. 1996; 35: 97-106.
91. Bacic G, Nilges MJ, Walczak T, Swartz HM. The use of in vivo EPR to follow the pharmacokinetics of drugs. Phys. Med. 1989; 5: 307-313.
92. Chan C, Magin RL, Swartz HM. Rapid assessment of liposomal stability in blood by an aqueous nitroxide spin label. Biochem. Biophys. Meth. 1989; 18: 271-276.
93. 2+ to murine liver. Magn. Reson. Med. 1990; 13: 44-61.
94. 2 as a liver specific contrast agent for magnetic resonance imaging. Invest. Radiol. 1990; 25: 545-551.
95. Iannone A, Magin RL, Walczak T, Federico M, Swartz HM, Tomasi A, Vannini V. Blood clearance of dextran magnetite particles determined by a non-invasive in vivo ESR method. Magn. Reson. Med. 1991; 22: 435-442.
96. Smirnova TI, Smirnov AI, Belford RL, Clarkson RB. Interaction of MRI gadolinium contrast agents with phospholipid bilayers as studied by 95 GHz EPR. Acta Chem. Scand. 1997; 51: 562-566.
97. Bhattacharyya J, Biswas S, Datta AG. Mode of action of endotoxin: role of free radicals and antioxidants. Curr. Med. Chem. 2004; 11: 359-368.
98. Mader K, Bacic G, Swartz HM. In vivo detection of anthralin-derived free radicals in the skin of hairless mice by low-frequency electron paramagnetic resonance spectroscopy. J. Invest. Derm. 1995; 104: 514-517.
99. 2, acute hypoxic hypoxia and volatile anesthetics in the rat brain. In Oxygen Transport to Tissue, Okunieff P (ed.). Plenum Press: New York, 2004 (in press).
100. 2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res. 1995; 685: 91-98.
101. Liu KJ, Hoopes PJ, Rolett EL, Beerle B, Azzawi A, Goda F, Dunn JF, Swartz HM. Effect of anesthesia on cerebral tissue oxygen and cardiopulmonary parameters in rats. Adv. Exp. Med. Biol. 1997; 428: 33-39.
102. Jiang J, Liu KJ, Shi X, Swartz HM. Detection of short-lived free radicals by low frequency ESR spin trapping in whole living animals: evidence of sulfur trioxide anion free radical generation in vivo. Arch. Biochem. Biophys. 1995; 319: 570-573.
103. Liu KJ, Jiang J, Swartz HM, Shi X. Low frequency EPR investigation on chromium (VI) reduction in whole mice. Arch. Biochem. Biophys. 1994; 313: 248-252.
104. Liu KJ, Shi X, Jiang J, Goda F, Dalal N, Swartz HM. Low frequency electron paramagnetic resonance investigation on metabolism of chromium (VI) by whole live mice. Ann. Clin. Lab. Sci. 1996; 26: 176-184.
105. Liu KJ, Mader K, Shi X, Swartz HM. Reduction of carcinogenic chromium (VI) on the skin of living rats. Magn. Reson. Med. 1997; 38: 524-526.
106. Gallez B, Mader K, Swartz HM. Noninvasive Measurement of the pH inside the gut using pH-sensitive nitroxides. An in vivo EPR study. Magn. Reson. Med. 1996; 36: 694-697.
107. Mader K, Gallez B, Liu KJ, Swartz HM. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials 1996; 4: 457-461.
108. Mader K, Bacic G, Domb A, Elmalak O, Langer R, Swartz HM. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J. Pharm. Sci. 1997; 86: 126-134.
109. Mader K. Pharmaceutical applications of in vivo EPR. Phys. Med. Biol. 1998; 43: 1931-1935.
110. Liu KJ, Miyake M, Panz T, Swartz HM. Evaluation of DEPMPO as a spin trapping agent in biological systems. Free Rad. Biol. Med. 1999; 26: 714-721.
111. Khan N, Wilmot CM, Rosen GM, Demidenko E, Sun J, Joseph J, O'Hara J, Kalyanaraman B, Swartz HM. Spin traps: in vitro toxicity and stability of radical adducts. Free Rad. Biol. Med. 2004; 11: 1473-1481.
112. Kocherginsky N, Swartz HM. Nitroxide Spin Labels, Reactions in Biology and Chemistry. CRC Press: Boca Raton, FL, 1995.
113. Swartz HM. Use of nitroxides to measure redox metabolism in cells and tissues. J. Chem. Soc., Faraday Trans. 1987; 1: 191-202.
114. He J, Beghein N, Ceroke P, Clarkson RB, Swartz HM, Gallez B. Development of biocompatible oxygen-permeable films holding paramagnetic carbon particles: evaluation of their performance and stability in EPR oximetry. Magn. Reson. Med. 2001; 46: 610-614.
115. Wütschert R, Bounameaux H. Predicting healing of arterial leg ulcers by means of segmental systolic pressure measurements. Vasa 1998; 27: 224-228.
116. 2. Diabetes Care 1997; 20: 1315-1318.
117. Fife CE, Buyukcakir C, Otto GH, Sheffield PJ, Warriner RA, Love TL, Mader J. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. Wound Repair Regen. 2002; 10: 198-207.